Liver cancers are the fourth leading cause of cancer-related mortality worldwide. In the past
decade, breakthroughs in the field of artificial intelligence (AI) have inspired development of …

Simple Summary Liver cancer is a major health problem worldwide, and its early detection
and management are imperative for improving patient outcomes. Biomarkers have great …

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and
currently the third-leading cause of cancer-related death worldwide. Recently, artificial …

Hepatocellular carcinoma (HCC) currently represents the fifth most common malignancy and
the third-leading cause of cancer-related death worldwide, with incidence and mortality rates …

Clinical routine in hepatology involves the diagnosis and treatment of a wide spectrum of
metabolic, infectious, autoimmune and neoplastic diseases. Clinicians integrate qualitative …

Although artificial intelligence (AI) was initially developed many years ago, it has
experienced spectacular advances over the last 10 years for application in the field of …

Hepatocellular carcinoma (HCC) is among the leading causes of cancer incidence and
death. Despite decades of research and development of new treatment options, the overall …

Background: Early-stage diagnosis and treatment can improve survival rates of liver cancer
patients. Dynamic contrast-enhanced MRI provides the most comprehensive information for …

BACKGROUND Prediction of survival after the treatment of hepatocellular carcinoma (HCC)
has been widely investigated, yet remains inadequate. The application of artificial …

Artificial Intelligence (AI) has recently been shown as an excellent tool for the study of the
liver; however, many obstacles still have to be overcome for the digitalization of real-world …